How much revenue does Medico Remedies make?

Medico Remedies reported 1.51 billion INR in revenue for fiscal year 2025, up 4.2% from 1.45 billion INR in fiscal year 2024. In Q3 2026 revenue was 586.83 million INR.

What companies are similar to Medico Remedies?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Genesis Ibrc India Ltd (GENESIS.BO), Ambalal Sarabhai Enterprises Limited (AMBALALSA.BO), Sanjivani Paranteral Limited (SANJIVIN.BO), Auro Laboratories Limited (AUROLAB.BO).

Medico Remedies Limited (MEDICO.NS) Stock

About Medico Remedies Limited

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics;...

At a glance

Medico Remedies reported revenue of 1.51 billion INR for fiscal year 2025, up 4.2% from fiscal year 2024, and net income of 100.93 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 586.83 million INR, up 48.6% from a year before.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.